NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9. [electronic resource]
Producer: 20120814Description: 36 p. digitalISSN:- 1742-2094
- Analysis of Variance
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Cells, Cultured
- Chemokine CCL2 -- metabolism
- Dexamethasone -- pharmacology
- Disease Models, Animal
- Enzyme-Linked Immunosorbent Assay
- Freund's Adjuvant
- Ganglia, Spinal -- cytology
- Gene Expression Regulation -- drug effects
- Hyperalgesia -- chemically induced
- Immediate-Early Proteins -- genetics
- Inflammation -- chemically induced
- Intercellular Signaling Peptides and Proteins -- genetics
- Male
- Matrix Metalloproteinase 2 -- genetics
- Matrix Metalloproteinase 9 -- metabolism
- Nerve Tissue Proteins -- metabolism
- Pain -- drug therapy
- Pain Measurement
- Pain Threshold -- drug effects
- RNA, Messenger -- metabolism
- RNA, Small Interfering -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Sensory Receptor Cells -- drug effects
- Spinal Cord -- pathology
- Time Factors
- Transfection
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.